Literature DB >> 30655300

New plugs for CCM bleeds.

Victoria L Bautch1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30655300      PMCID： PMC6337878          DOI： 10.1182/blood-2018-11-887539

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  10 in total

Review 1.  Endothelial cell disease: emerging knowledge from cerebral cavernous malformations.

Authors:  Maria Grazia Lampugnani; Matteo Malinverno; Elisabetta Dejana; Noemi Rudini
Journal:  Curr Opin Hematol       Date:  2017-05       Impact factor: 3.284

2.  Endothelial Kruppel-like factor 4 protects against atherothrombosis in mice.

Authors:  Guangjin Zhou; Anne Hamik; Lalitha Nayak; Hongmei Tian; Hong Shi; Yuan Lu; Nikunj Sharma; Xudong Liao; Andrew Hale; Lauren Boerboom; Ryan E Feaver; Huiyun Gao; Amar Desai; Alvin Schmaier; Stanton L Gerson; Yunmei Wang; G Brandon Atkins; Brett R Blackman; Daniel I Simon; Mukesh K Jain
Journal:  J Clin Invest       Date:  2012-11-19       Impact factor: 14.808

3.  EndMT contributes to the onset and progression of cerebral cavernous malformations.

Authors:  Luigi Maddaluno; Noemi Rudini; Roberto Cuttano; Luca Bravi; Costanza Giampietro; Monica Corada; Luca Ferrarini; Fabrizio Orsenigo; Eleanna Papa; Gwenola Boulday; Elisabeth Tournier-Lasserve; Françoise Chapon; Cristina Richichi; Saverio Francesco Retta; Maria Grazia Lampugnani; Elisabetta Dejana
Journal:  Nature       Date:  2013-06-09       Impact factor: 49.962

4.  Defining the regulation of KLF4 expression and its downstream transcriptional targets in vascular endothelial cells.

Authors:  Guadalupe Villarreal; Yuzhi Zhang; H Benjamin Larman; Jorge Gracia-Sancho; Andrew Koo; Guillermo García-Cardeña
Journal:  Biochem Biophys Res Commun       Date:  2009-12-05       Impact factor: 3.575

5.  Cerebral cavernous malformations form an anticoagulant vascular domain in humans and mice.

Authors:  Miguel Alejandro Lopez-Ramirez; Angela Pham; Romuald Girard; Tine Wyseure; Preston Hale; Atsuki Yamashita; Janne Koskimäki; Sean Polster; Laleh Saadat; Ignacio A Romero; Charles T Esmon; Frederic Lagarrigue; Issam A Awad; Laurent O Mosnier; Mark H Ginsberg
Journal:  Blood       Date:  2018-11-15       Impact factor: 22.113

6.  Lesions from patients with sporadic cerebral cavernous malformations harbor somatic mutations in the CCM genes: evidence for a common biochemical pathway for CCM pathogenesis.

Authors:  David A McDonald; Changbin Shi; Robert Shenkar; Carol J Gallione; Amy L Akers; Stephanie Li; Nicholas De Castro; Michel J Berg; David L Corcoran; Issam A Awad; Douglas A Marchuk
Journal:  Hum Mol Genet       Date:  2014-04-03       Impact factor: 6.150

7.  The cerebral cavernous malformation signaling pathway promotes vascular integrity via Rho GTPases.

Authors:  Kevin J Whitehead; Aubrey C Chan; Sutip Navankasattusas; Wonshill Koh; Nyall R London; Jing Ling; Anne H Mayo; Stavros G Drakos; Christopher A Jones; Weiquan Zhu; Douglas A Marchuk; George E Davis; Dean Y Li
Journal:  Nat Med       Date:  2009-01-18       Impact factor: 53.440

8.  KLF4 is a key determinant in the development and progression of cerebral cavernous malformations.

Authors:  Roberto Cuttano; Noemi Rudini; Luca Bravi; Monica Corada; Costanza Giampietro; Eleanna Papa; Marco Francesco Morini; Luigi Maddaluno; Nicolas Baeyens; Ralf H Adams; Mukesh K Jain; Gary K Owens; Martin Schwartz; Maria Grazia Lampugnani; Elisabetta Dejana
Journal:  EMBO Mol Med       Date:  2016-01-01       Impact factor: 12.137

9.  Cerebral cavernous malformations arise from endothelial gain of MEKK3-KLF2/4 signalling.

Authors:  Zinan Zhou; Alan T Tang; Weng-Yew Wong; Sharika Bamezai; Lauren M Goddard; Robert Shenkar; Su Zhou; Jisheng Yang; Alexander C Wright; Matthew Foley; J Simon C Arthur; Kevin J Whitehead; Issam A Awad; Dean Y Li; Xiangjian Zheng; Mark L Kahn
Journal:  Nature       Date:  2016-03-30       Impact factor: 49.962

10.  Thrombospondin1 (TSP1) replacement prevents cerebral cavernous malformations.

Authors:  Miguel Alejandro Lopez-Ramirez; Gregory Fonseca; Hussein A Zeineddine; Romuald Girard; Thomas Moore; Angela Pham; Ying Cao; Robert Shenkar; Bart-Jan de Kreuk; Frederic Lagarrigue; Jack Lawler; Christopher K Glass; Issam A Awad; Mark H Ginsberg
Journal:  J Exp Med       Date:  2017-09-28       Impact factor: 14.307
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.